New Horizon Health Limited

New Horizon Health Limited (Incorporated in the Cayman Islands with limited liability) Company Overview Founded in 2015, New Horizon Health is the pioneer and leader in Chinas cancer screening market, with a vision to prevent and cure cancer by screening and early detection. Company has two commercialized medical tests for colorectal cancer screening, and two late-stage pipeline candidates for gastric and cervical cancer screening respectively. Company holds global rights to all its marketed and pipeline products. A home-based, non-invasive, national-guideline-recommended FIT-DNA test targeting 120 million colorectal high-risk population in China, ColoClear is the first and only cancer screening test approved by NMPA. Pupu Tube, NMPA approved and CE Mark obtained, is the first self-conducted FIT screening test targeting 630 million population to identify colorectal high-risk individuals in China. In addition, Company has a synergistic screening pipeline portfolio focusing on high-i...